Evidence map›Paper›PMID 40169634›Full record

ArticleScientific reports2025

Improved gated recurrent unit-based osteosarcoma prediction on histology images: a meta-heuristic-oriented optimization concept.

S Prabakaran, S Mary Praveena

Abstract read
In one paragraph

Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

S PrabakaranDepartment of ECE, CMS College of Engineering and Technology, Coimbatore, Tamilnadu, 641032, India. sprabakaran87@gmail.com.
S Mary PraveenaDepartment of ECE, Sri Ramakrishna Institute of Technology, Coimbatore, Tamilnadu, 641022, India.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The major prevalent primary bone cancer is osteosarcoma. Preoperative chemotherapy is accompanied by resection as part of the normal course of treatment. The diagnosis and treatment of patients are based on the chemotherapy reaction. Contrarily, chemotherapy without operation results in persistent cancer and an osteosarcoma regrowth. Thus, osteosarcoma patients should receive comprehensive therapy, which includes tumor-free surgery and global chemotherapy, to improve their survival. Hence, early diagnosis and individualized care of osteosarcoma are essential since they may lead to more effective therapies and higher survival rates. Here, the main goal of the recommended research is to use a unique deep learning approach to predict the osteosarcoma on histology images. Initially, the data is collected from the navigation confluence mobile osteosarcoma data of UT Southwestern/UT Dallas dataset. Next, the pre-processing of the collected images is accomplished by the Weiner filter technique. Further, the segmentation for the pre-processed images is done by the 2D Otsu's method. From the segmented images, the features are extracted by the linear discriminant analysis (LDA) approach. These extracted features undergo the final prediction phase that is accomplished by the novel improved recurrent gated recurrent unit (IGRU), in which the parameter tuning of GRU is accomplished by the osprey optimization algorithm (OOA) with the consideration of error minimization as the major objective function. On contrast with various conventional methods, the simulation findings demonstrate the effectiveness of the developed model in terms of numerous analysis.

Indexed as

Bone NeoplasmsImage Processing, Computer-AssistedOsteosarcomaAlgorithmsDeep LearningHumansHistology imagesImproved gated recurrent unitOsprey optimization algorithmOsteosarcoma prediction

Identifiers

PMID40169634
PMCPMC11961726

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.